Predicting Parkinson's disease trajectory using clinical and functional MRI features: a reproduction and replication study
Parkinson's disease (PD) is a common neurodegenerative disorder with a poorly understood physiopathology and no established biomarkers for the diagnosis of early stages and for prediction of disease progression. Several neuroimaging biomarkers have been studied recently, but these are susceptible to several sources of variability related for instance to cohort selection or image analysis. In this context, an evaluation of the robustness of such biomarkers to variations in the data processing workflow is essential. This study is part of a larger project investigating the replicability of potential neuroimaging biomarkers of PD. Here, we attempt to reproduce (re-implementing the experiments with the same data, same method) and replicate (different data and/or method) the models described in [1] to predict individual's PD current state and progression using demographic, clinical and neuroimaging features (fALFF and ReHo extracted from resting-state fMRI). We use the Parkinson's Progression Markers Initiative dataset (PPMI, ppmi-info.org), as in [1] and aim to reproduce the original cohort, imaging features and machine learning models as closely as possible using the information available in the paper and the code. We also investigated methodological variations in cohort selection, feature extraction pipelines and sets of input features. Different criteria were used to evaluate the reproduction and compare the reproduced results with the original ones. Notably, we obtained significantly better than chance performance using the analysis pipeline closest to that in the original study (R2 \> 0), which is consistent with its findings. Moreover, using derived data provided by the authors of the original study, we were able to make an exact reproduction and managed to obtain results that were close to the original ones. The challenges encountered while reproducing and replicating the original work are likely explained by the complexity of neuroimaging studies, in particular in clinical settings. We provide recommendations to further facilitate the reproducibility of such studies in the future.
Code (1)
Similar Papers 제목 키워드 기반
Edge-boosted graph learning for functional brain connectivity analysis
Predicting disease states from functional brain connectivity is critical for the early diagnosis of severe neurodegenerative diseases such as Alzheimer's Disease and Parkinson's Disease. Existing studies commonly employ …
Functional ConnectivityGraph LearningLongitudinal Prognosis of Parkinsons Outcomes using Causal Connectivity
Parkinsons disease (PD) is a movement disorder and the second most common neurodengerative disease but despite its relative abundance, there are no clinically accepted neuroimaging biomarkers to make prognostic predictio…
DiagnosticPrognosisDeep Learning Predicts Prevalent and Incident Parkinson's Disease From UK Biobank Fundus Imaging
Parkinson's disease is the world's fastest-growing neurological disorder. Research to elucidate the mechanisms of Parkinson's disease and automate diagnostics would greatly improve the treatment of patients with Parkinso…
DiagnosticParkinson’s Disease EMG Signal Prediction Using Neural Networks
This paper proposes a comparison between different neural network models, using multilayer perceptron (MLPs) and recurrent neural network (RNN) models, for predicting Parkinson's disease electromyography (EMG) signals, t…
Electromyography (EMG)EMG Signal PredictionPredictionInterpretable machine learning predicts Parkinson's disease severity using motion-corrected QSM MRI and multiband multiecho fMRI features
Introduction: Objective neuroimaging biomarkers may improve Parkinson's disease motor assessment by capturing brain variation not directly observable from clinical examination. We used interpretable machine learning to p…
Interpretable Machine Learning